Vlad Vitoc
Amministratore Delegato presso MAIA BIOTECHNOLOGY, INC.
Patrimonio netto: 5 M $ in data 31/05/2024
Posizioni attive di Vlad Vitoc
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Amministratore Delegato | 03/08/2018 | - |
| Presidente | 03/08/2018 | - | |
| Fondatore | 03/08/2018 | - | |
| Presidente | 03/08/2018 | - | |
DGD Pharmaceuticals Corp.
 DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - |
Storia della carriera di Vlad Vitoc
Formazione di Vlad Vitoc
| University of South Carolina | Masters Business Admin |
| Iuliu Hatieganu University of Medicine & Pharmacy | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Romania | 2 |
Posizioni
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MAIA BIOTECHNOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
DGD Pharmaceuticals Corp.
DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Health Technology |
- Borsa valori
- Insiders
- Vlad Vitoc
- Esperienza
